XLerator Network Selects Innovators Across Southeast for NIH-Funded Entrepreneurship Program (feat. KY, LA, MS, SC, WV)
XLerateHealth, has announced the selection of nine innovators across the Southeast IDeA State region to participate in the NIH-funded IDeA Regional Entrepreneurship Development (I-RED) Program. Participants were selected through a competitive application. The goal of the I-RED program is to help selected participants acquire the fundamental business and entrepreneurial skills needed to successfully commercialize their technologies.
Members of the inaugural cohort are:
- Marc Birtwistle, PhD, Co-founder and CEO of Blotting Innovations (Clemson University, SOUTH CAROLINA)
- David Colby, PharmD, PhD, Founder of Fluoriq (University of MISSISSIPPI)
- Michael Dunham, MD, Co-founder and CEO of Soteria Medical Solutions (LOUISIANA State University Health Sciences)
- Jill Kolesar, PharmD, Founder of VesiCure Technologies (University of KENTUCKY)
- Nina McLain, RN, PhD, Founder and CEO of OSD Technologies (University of Southern MISSISSIPPI) Jeremy Mercuri, PhD, Founder and Chief Scientific Officer of NovaVia Spine & Biologics (Clemson University, SOUTH CAROLINA)
- Jay Potts, PhD, Co-founder and CEO of Carolina Biologics (University of SOUTH CAROLINA)
- Shafic Sraj, MD, MBA (WEST VIRGINIA University)
- Stephen Valentine, PhD, Co-founder and Vice President of Invibragen (WEST VIRGINIA University)
"We are grateful to the NIH for supporting academic technology commercialization and bringing valuable resources to researchers and clinicians in the IDeA States. We are excited about the nine innovators selected to participate in the inaugural I-RED cohort, and the XLN’s External Advisory Committee was delighted to have been part of the selection process,” said Dr. David McLoughlin, Vice President, Seagen, and Chair, External Advisory Committee, XLerator Network.